BIAsp-70

biphasic insulin aspart protamine 70% / insulin aspart 30% · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIAsp-70, covering 2017-01-06 to 2017-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes [Phase 3]

See pricing